Azora Therapeutics, Inc. AZR
3.87 USD +0.07 (+1.84%)
Regular-session close
4.00 +0.13 +3.36%
Pre-market · Nov 20, 4:38 AM ET
3.60 Day range 4.10
1.31 52-week range 8.25
- YTD
- -29.64%
- 1 year
- -51.63%
No chart data for this range yet.
- Market cap
- 55.29M
- EPS (ttm)
- -18.09
- YTD return
- -29.64%
- 1-year return
- -51.63%
- Volume
- 85.78K
- Avg volume
- 50.06K
- Open
- 4.10
- Previous close
- 3.80
- Day's range
- 3.60 – 4.10
- 52-week range
- 1.31 – 8.25
Fundamental scorecard
6 of 25 checks passed on AZR’s reported financials
6of 25 checks passed
- Value 0 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
AZR Revenue — quarterly 0
AZR Net income — quarterly -64.56M
AZR EPS — quarterly -4.52
News
Azora Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Azora Therapeutics Files Prospectus For $250M Mixed Securities Shelf; May Sell Up To $20M Of Stock Under Sales Agreement With Jefferies
Jones Trading Initiates Coverage On Azora Therapeutics with Buy Rating, Announces Price Target of $14
12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on AZR — it syncs with the Stock Master app.
